Ikarian Capital »

Hookipa Pharma shares owned by Ikarian Capital

Quarter-by-quarter ownership of Hookipa Pharma (HOOK) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Hookipa Pharma

Tip: Access up to 7 years of quarterly data

All positions including Hookipa Pharma held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hookipa Pharma by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $228k 53k 4.30

More positions owned by Ikarian Capital

Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Amgen Call Option (AMGN)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Tarsus Pharmaceuticals (TARS)
Beigene Sponsored Adr Call Option (BGNE)
Anaptysbio Inc Common Put Option (ANAB)
Crinetics Pharmaceuticals In (CRNX)
Celldex Therapeutics Com New Put Option (CLDX)
Soleno Therapeutics Call Option (SLNO)
Janux Therapeutics Put Option (JANX)
Biohaven Put Option (BHVN)
Miragen Therapeutics Call Option (VRDN)
Immunovant Call Option (IMVT)
Capricor Therapeutics Com New Put Option (CAPR)
Arcus Biosciences Incorporated Call Option (RCUS)

View all positions for Ikarian Capital

Top funds holding Hookipa Pharma

Baker Bros. Advisors
Siren
Bank of America Corporation
Redmile Group
Acadian Asset Management
Geode Capital Management
Ikarian Capital
Dimensional Fund Advisors
Renaissance Technologies
Royal Bank of Canada
GSA Capital Partners
Northern Trust
Citadel Advisors
BlackRock
Group One Trading

View all funds holding Hookipa Pharma